We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
DNA methylation in Friedreich ataxia silences expression of frataxin isoform E.
- Authors
Rodden, Layne N.; Gilliam, Kaitlyn M.; Lam, Christina; Rojsajjakul, Teerapat; Mesaros, Clementina; Dionisi, Chiara; Pook, Mark; Pandolfo, Massimo; Lynch, David R.; Blair, Ian A.; Bidichandani, Sanjay I.
- Abstract
Epigenetic silencing in Friedreich ataxia (FRDA), induced by an expanded GAA triplet-repeat in intron 1 of the FXN gene, results in deficiency of the mitochondrial protein, frataxin. A lesser known extramitochondrial isoform of frataxin detected in erythrocytes, frataxin-E, is encoded via an alternate transcript (FXN-E) originating in intron 1 that lacks a mitochondrial targeting sequence. We show that FXN-E is deficient in FRDA, including in patient-derived cell lines, iPS-derived proprioceptive neurons, and tissues from a humanized mouse model. In a series of FRDA patients, deficiency of frataxin-E protein correlated with the length of the expanded GAA triplet-repeat, and with repeat-induced DNA hypermethylation that occurs in close proximity to the intronic origin of FXN-E. CRISPR-induced epimodification to mimic DNA hypermethylation seen in FRDA reproduced FXN-E transcriptional deficiency. Deficiency of frataxin E is a consequence of FRDA-specific epigenetic silencing, and therapeutic strategies may need to address this deficiency.
- Subjects
FRATAXIN; DNA methylation; ATAXIA; MITOCHONDRIAL proteins; PROTEIN deficiency; GENE silencing
- Publication
Scientific Reports, 2022, Vol 12, Issue 1, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-022-09002-5